are tirzepatide tablets fda approved Tablet: Oral Format Facts A Doctor's Perspective on FDA-

thus, they are an attractive therapeutic option for patients with type 2 diabetes, especially those with existing cardiovascular disease or at high risk for those complications

Following all protocols optimizes chances of achieving upper range results

Suicidality concerns: what we know now Regulatory reviews by the FDA and EMA have not found evidence that GLP-1s cause suicidal thoughts or behaviors, though monitoring continues (FDA, 2024

It is best to take the tablet with water, either before or after meals

Unlike in some other countries, tirzepatide does not currently have UK marketing authorisation specifically for weight management